chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Woke up in the morning and tongue was numb and tingling. Symptoms lasted until the following morning.
Site: Pain at Injection Site-Mild, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: PATIENT CAME TO THE PHARMACY 2 DAYS AFTER THE VACCINE WAS GIVEN TO REPORT SWOLLEN LIP. SHE WAS UNSURE IF IT WAS VACCINE RELATED OR SOMETHING ELSE.
Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Additional Details: Patient reporting having chills about 5 minutes post-booster injection. Emergency medical services (911) were dispatched. Upon arrival of the paramedics, patient's blood pressure stabilized and patient refused to be transported to the hospital. Followed up with the patient via telephone ~1 hour post-adverse event and the patient reported to be feeling better.
Approximately 10 minutes after receiving the vaccine, the patient stated that he was feeling hot and short of breath. He then lost consciousness for about 30 seconds. The patient's upper extremities shook during this time. After the patient regained consciousness, he was oriented to person/place only. The patient's vital signs remained stable throughout.
Cellulitis (L) deltoid. KEFLEX 500mg TID x10d. BENADRYL 25mg.
30 minutes after receiving injection, developed swollen, itchy eyes. Swelling still present but reduced as of 01/22/2021. OTC antihistamines helping.
Symptoms started approximately 13 hours after the injection. I had uncontrollable shivering (chills). The next day I felt like I had the flu: achy, a bad headache, extreme soreness at injection site, with redness and swelling, great fatigue (I slept most of the day). Day two after the injection I feel moderately better, but am still achy and fatigued.
6 weeks after vaccine I developed vertigo that won't clear with Eppley maneuver and now excessive tinnitus.
Sore Mouth; "Foggy Brain"; Body Ache; Itchiness; Fever of 104 Degrees; Chills; Fatigue; Headache; Nausea; Injection site redness; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of ORAL PAIN (Sore Mouth), FEELING ABNORMAL ("Foggy Brain"), PAIN (Body Ache), VACCINATION SITE PRURITUS (Itchiness) and PYREXIA (Fever of 104 Degrees) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), ESZOPICLONE (LUNESTA), THYROID (ARMOUR THYROID) and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ORAL PAIN (Sore Mouth), FEELING ABNORMAL ("Foggy Brain"), PAIN (Body Ache), VACCINATION SITE PRURITUS (Itchiness), PYREXIA (Fever of 104 Degrees), CHILLS (Chills), FATIGUE (Fatigue), HEADACHE (Headache), NAUSEA (Nausea), VACCINATION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE SWELLING (Swelling). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and HYDROGEN PEROXIDE (PEROXIDE) at an unspecified dose and frequency. At the time of the report, ORAL PAIN (Sore Mouth), FEELING ABNORMAL ("Foggy Brain"), PAIN (Body Ache), VACCINATION SITE PRURITUS (Itchiness), PYREXIA (Fever of 104 Degrees), CHILLS (Chills), FATIGUE (Fatigue), HEADACHE (Headache), NAUSEA (Nausea), VACCINATION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 104 degree (plane angle) High.
Hot, swollen, painful lymph nodes, temp 100.1F, pain of ovaries
Pt received vaccine at 10:05 am and at 10:20 am observer Marco informed, RN that pt was feeling something in her throat. Pt was moved from observation area to Triage area.  I was informed shortly after that, that pt felt something in her throat. I then went to check on pt/nurse.  Pt stated that she felt some tightening in her throat but no difficulty breathing, no throat closure. Years ago she had an anaphylactic reaction to Demerol so she knows what it feels like and this didn't feel the same. As soon as RN took vitals pt stated that she started to feel better. Vitals were taken x3.  Last vital was taken at 10:39 am and pt no longer felt anything in her throat.  Pt walked out of clinic at  10:42 with
Patient reported to me that the developed tinitis in both ears 2-3 days following vaccination. The ringing is constant with the patient's left ear being much more severe.
On June 4th 1999 the pt developed possible chickenpox with a small area of rash and a lesion on his arm that did not look like a vesicle. The pt was afebrile. There was no pruritus or drainage.
Four days after 2nd shot my arm became more painful and itchy.  It continued to increase and became obvious it was a rash.  Small bumps appeared and spread further away from the injection site but close and extended around my upper arm about  3 inches wide and 4 -5 inches long.  This became very itchy.  As of today it is no longer itchy but from scratching the spots are still visible.  The little scabs from scratching will go away.
LVN was administering the COVID vaccine and while preparing, patient's husband was attempting to video it. At this time nurse explained she wasn't very comfortable with it and that he can take a picture of her arm as she didn't want to be in the picture. She was distracted and went to give the vaccine puncturing skin and she realized the syringe was empty. She did NOT express air she withdrew the needle disposed of it in the sharps. Made the patient aware and asked if she wanted anyone else to vaccinate her and she said no she felt fine. She didn't even feel the puncuture. She had no adverse reactions and felt fine.
Pt was ordered MENVEO a 2nd dose and BEXSERO 1st dose. Pt RECEIVED BEXSERO and TRUMENBA instead of MENVEO.
SEVERE VERTIGO; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via an unspecified route of administration in the arm left on 09Mar2021 at 12:15 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history was reported no. The patient did not receive concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:EN6200) via an unspecified route of administration in the arm left on 16Feb2021 at 13:00 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior  the vaccination. The patient did not have Allergies to medications, food, or other product. On 15Mar2021 at 08:45 the patient was experienced severe vertigo. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of  severe vertigo was ongoing.    No follow-up attempts are needed. No further information is expected.
Rash began on stomach and legs consisting of small red circles. Within 24 hours the rash spread across entire body.
Patient received 2nd dose of Pfizer Covid-19 vaccine at 3:52 PM and was accompanied by his mother. Patient remained seated in the vaccination seat the entire time. As soon as he put his head back on the chair, i stood next to him and held him. His eyes were open. Patient reported passing out for a minute, threw up a little, and looked like he had a seizure. The paramedics were called. His vitals were normal. At 4:25 PM, he reported still feeling nauseous and his mother decided to take him to emergency room. Patient walked out of the pharmacy unaided.
Starting about 6 hours after injection: Soreness at injection site;; Stiffness when raising arm; Chills starting about 8 hours after injection, lasting about 28 hour; Dose: 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 26Nov2021 11:15 (Lot number: 30155BA) at the age of 66 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: MAGNESIUM CITRATE. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Lot #EN6200), administration date: 20Feb2021, for COVID-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: Lot #EN6199), administration date: 13Mar2021, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 26Nov2021 11:15, outcome "unknown", described as "Dose: 3"; VACCINATION SITE PAIN (non-serious) with onset 26Nov2021 17:15, outcome "recovered" (2021), described as "Starting about 6 hours after injection: Soreness at injection site;"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 26Nov2021 17:15, outcome "recovered" (2021), described as "Stiffness when raising arm"; CHILLS (non-serious) with onset 26Nov2021 17:15, outcome "recovered" (Nov2021), described as "Chills starting about 8 hours after injection, lasting about 28 hour". Therapeutic measures were not taken as a result of vaccination site pain, musculoskeletal stiffness, chills.  Additional information: Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  No follow-up attempts are possible. No further information is expected.
Temperature of 102.3. Head started shaking jerking his arms (twitch for about an hour). Acted 'dopey and out of it' for an hour or so. Mother states child has made a complete recovery.
Site: Pain at Injection Site-Medium, Systemic: Joint Pain-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
nausea; dizziness; heart raising; Bed spinning; She experienced on and off fever; chills; diarrhea; it makes eating really hard; Anxiety; This is a spontaneous report from a contactable consumer (patient). A 39-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8727), dose 1 via an unspecified route of administration, administered in left arm on 22Jul2021 as dose 1, single for COVID-19 immunization (at the age of 39-year-old). Medical history included extremely sensitive to pharmaceuticals. The patient's concomitant medications were not reported. No prior vaccinations within 4 weeks. On an unspecified date in Jul2021, the patient experienced on and off fever, chills, diarrhea, it makes eating really hard and anxiety. On 22Jul2021, the patient experienced nausea, dizziness, heart raising and bed spinning. No visits of Emergency Room and Physician Office. On an unspecified date in Jul2021, the patient underwent lab tests and procedures which included fever: 100-101 (it would spike up to  around 100-101 degrees). The outcome of the event on and off fever, chills and anxiety was not recovered. The outcome of the events nausea, dizziness, diarrhea and bed spinning was recovering and unknown for all other events.  Follow-up attempts are completed. No further information is expected.
The coroner said it was some type of heart attack; A spontaneous Report Received from a Health care professional concerning a 84 year old male patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and who experienced a heart attack / myocardial infarction.  The patient's had undergone triple bypass surgery years ago. Concomitant medications were vitamins.  On 18-Jan-2021 prior to onset of events the patient received his first of first two planned doses of (mRNA-1273) COVID-19 vaccine of unknown batch no, unknown route and unknown site of administration for prophylaxis of COVID-19 infection.  On 13-Feb-2021 the patient experienced death 27 days after the first dose of the vaccine. The coroner said it was some type of heart attack and think he expired sometime Saturday 13-Feb-2021.  On 16-Feb-2021 the patient was supposed to have his second dose of (mRNA-1273) COVID-19 vaccine.  The event, heart attack, was fatal.; Reporter's Comments: This is a case of death to heart attack in a 84-year-old female subject with a hx of triple bypass surgery, who died 27 days after receiving first dose of vaccine. Very limited information has been provided at this time. No death certificate provided. Further information has been requested.; Reported Cause(s) of Death: Unknown cause of Death
ACHES; ILL; FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced aches, ill, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not reported. The patient recovered from aches, ill, and fever. This report was non-serious.
Patient presented with widespread rash 5 days post immunization. Patient consulted primary care physician and is being treated with topical and oral steroid. Patient cites she has underlying eczema and it was slightly flaring before immunization, but now is far worse.
Pt seen at COVID vaccination event at her adult health care facility. 17 min post vaccination pt complained of itchy throat,  "funny feeling" and "just feel off."  Pt evaluated by RN and no s/s of anaphylaxis including no respiratory distress, low 02, no evidence of uticaria or angioedema.  21 min post vaccination pt given 12.5 mg diphenhydramine IM in different limb from vaccination.  RN continued to monitor and no changes in symptoms and no deterioration in symptoms or vitals.  34 min post vaccination another 12.mg diphenhydramine IM administered in different limb from vaccination and continued monitoring by RN with no changes in vitals and no s/s of anaphylaxis.  At 11 am pt reported "feeling fine" with no distress.  Pt discharged from RN supervision with complaints resolved.
Information has been received from a nurse practitioner concerning a 16 year old female, who, on an unspecified date, was vaccinated intramuscularly with a second dose of Gardasil. Subsequently, the patient passed out in the car about 15 minutes post vaccination. The nurse practitioner reported that the patient mentioned that she had cleaned her backroom that morning with Tilex and really had nothing substantial to eat besides popcorn and pineapple that day. The patient ended up going to the emergency room. At the time of the report, the patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 19-year-old female patient who received BEXSERO for prophylaxis. Concurrent medical conditions included drug hypersensitivity. On 31st October 2018, the patient received BEXSERO. On an unknown date, 3 days after receiving BEXSERO, the patient experienced fatigue, general body pain, nausea, headache, neck pain, pain in hand, muscle pain and joint pain. On an unknown date, the outcome of the fatigue, general body pain, nausea, headache, neck pain, pain in hand, muscle pain and joint pain were not recovered/not resolved. It was unknown if the reporter considered the fatigue, general body pain, nausea, headache, neck pain, pain in hand, muscle pain and joint pain to be related to BEXSERO. Additional details were reported as follows: This case was reported by the patient's mother. The patient received BEXSERO on right arm. Three days following the vaccination, the patient experienced symptoms of fatigue, body aches, nausea, pain at injection site, headache and neck pain. The fatigue was so severe that, she stayed in bed all day. The injection pain went down to her hand where there was a spot which was very tender. The body aches were throughout her muscles and joints. The reporter gave consent to follow up.
8JUL96 in PM t102-103, dec appetite, inc crying, inc drooling, threw fits, loss of equilibrium;s/s persisted x 3 days;MOC reports totally different child;had only 2oz formula in 4 days, 2oz juice,H20, popsicles;severe rxn to vaxs;
Pruritus at injection site immediately after administration.  Swelling and redness of 1 cm diameter or less up to 12 hours after administration that grew and worsened to 3 inches by 2 inch round red local swelling with tenderness and mild warmth.  Patient was examined for this reaction about 48 hours after administration
Infanrix administered to a 12 years-old; Received Infanrix instead of Menveo; recreived Infanrix and Boostrix on the same day; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 12-year-old male patient who received DTPa (Infanrix) (batch number LS444, expiry date 16th September 2023) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis and DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On 10th August 2022, the patient received Infanrix, Infanrix Pre-Filled Syringe Device and Boostrix. On 10th August 2022, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device and not applicable after receiving Boostrix, the patient experienced inappropriate age at vaccine administration, wrong vaccine administered and overdose. On an unknown date, the outcome of the inappropriate age at vaccine administration, wrong vaccine administered and overdose were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 6-Jan-2023 Reporter's comment: The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up via postal. Additional supportive information: The patient received both Infanrix and Boostrix on the same day, but was supposed to get Boostrix and Menveo, which led to wrong vaccine administered and overdose. The patient received the Infanrix vaccine at an inappropriate age, which led inappropriate age at vaccine administration.
Client complained of dizziness 10 minutes post vaccine administration. Recovered quickly after laying down in health office. Released to clinic area 15 minutes later.
Strong pain in the entire arm, loss of sensitivity in my left hand. It fills like my entire arm was without circulation, my hand got cold at the touch. Paramedics took my blood pressure and were at 130/81, they also make an ECG and I had normal heart rhythm without tachycardia. It's been 6 hours since I got the vaccine and still fill crams in my entire left arm. Also, develop a mild fever.
On March 30th I developed a raised, swollen red patch at injection site and another raised red patch above. 12 hours later the rash began to itch.
got covid shot in right arm, next day arm was sore, a few days later arm really sore  and in pain kept getting worse trouble using arm and now left arm is in pain, hard to use both arms
Noticed blood in my urine that progressively became worse from 2pm Thursday May 6 to when I went to the ER on the morning of Friday May 7. The ER took urine tests and confirmed that blood was present in my urine - my urine was red in color. They did a CT scan of my lower abdomen. No kidney stones or other obstructions or damage were seen.  My temperature went up to 99 degrees. I was treated with antibiotics and discharged. No pain, just slightly elevated temperature and the blood in my urine. The blood in my urine subsided 24 hours after the hospital visit. I was left feeling very fatigued and it was hard to stay awake. Over a week later, I still have low energy levels. My GP said to report this.
Starting in the 9th, I began to feel very dizzy and experiencing vertigo but on the 10th, I was working (I?m a server) and with every movement I did or turn I took, I felt like I was gonna faint because of how dizzy I was feeling. It seems like I was doing too much movement to my body. Once having this effect, even when I sit or lay down, the room seems to be spinning.
Chills; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment reported.   This case was linked to MOD-2021-340922, MOD-2021-340951 (Patient Link).
Mom called on 10/11/02 stating child had a reaction to left arm, redness, swelling, no fever. She took patient to a doctor. Child was put on an antibiotic. I called on 10/15/02 to see how patient was doing. Mom states he is fine, much better.
dizziness; vertigo; This case was reported by a other health professional via interactive digital media and described the occurrence of dizziness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, 2 days after receiving Shingrix, the patient experienced dizziness and vertigo. On an unknown date, the outcome of the dizziness and vertigo were unknown.   It was unknown if the reporter considered the dizziness and vertigo to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as an adult as per the vaccine indication. The patient experienced dizziness, vertigo after vaccination.